65PA novel recombinant human anti-PD-1 monoclonal antibody GLS-010 in patients with advanced cancer: Result of a phase Ia clinical trial. (17th December 2018) - Shen, L; Gong, J; Xu, Y; Zhang, X; Peng, Z; Qi, C; Li, G; Meng, H; Liu, Z; Wang, H; Chen, C; Li, J; et al.